This interview follows breaking news released earlier this week that a new malaria drug, Tafenoquine, had been endorsed by the FDA. The drug treats relapsing P.vivax malaria and removes the malaria parasite from the liver.

Some have hailed the drug’s approval as ‘good news’, notably the Bill and Melinda Gates Foundation, but many have been quick to criticize the FDA. Tafenoquine can have harmful side effects, some of which are neuropsychiatric and can have fatal consequences.

Dr Remington Nevin is, I guess, the leader of the opposition. He runs an organisation lobbying against certain antimalarial drugs, such as Tafenoquine.

This is Five Minutes with Dr Remington Nevin.